Novartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program

    NEXT STORY
    Nevada Gold Mines Provides Covid-19 Support for Local Communities
    PREV STORY
    Dynavax Provides Business Update on COVID-19 Pandemic Impact
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    NGM Bio Expands Board of Directors with Appointment of Carole Ho, M.D.

    author_avatar
    NASDAQ Market News

    Immune Design Announces Presentations at the 2017 ASCO Annual Meeting

    SEATTLE and SOUTH SAN FRANCISCO, Calif., April 20, 2017 (GLOBE NEWSWIRE) -- Immune Design ...

    author_avatar
    NASDAQ Market News

    Precision Therapeutics to Hold Business Update Conference Call on April 2, 2018

    MINNEAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

    author_avatar
    NASDAQ Market News